India: Lupin launches Molnulup for COVID-19 treatment
New Delhi, Jan 7 (PTI) Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup in the country for the treatment of COVID-19.
Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation.
"The approval for Molnulup is timely as India is again experiencing an upward spike in COVID-19 incidences.
- Read more about India: Lupin launches Molnulup for COVID-19 treatment
- Log in or register to post comments